stable coronary artery disease Clinical Trials

3 recruitingLast updated: May 5, 2026

There are 7 actively recruiting stable coronary artery disease clinical trials across 4 countries. Studies span Not Applicable, Phase 1, Phase 3. Top locations include Beijing, Beijing Municipality, China, Bialystok, Poland, Bydgoszcz, Poland. Updated daily from ClinicalTrials.gov.


stable coronary artery disease Trials at a Glance

7 actively recruiting trials for stable coronary artery disease are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Beijing, Bialystok, and Bydgoszcz. Lead sponsors running stable coronary artery disease studies include Beijing Anzhen Hospital, Cardiovascular Investigation Unit, Royal Adelaide Hospital, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse stable coronary artery disease trials by phase

About stable coronary artery disease Clinical Trials

Looking for clinical trials for stable coronary artery disease? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new stable coronary artery disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about stable coronary artery disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease

stable coronary artery diseaseHealthy Volunteers
Hoffmann-La Roche196 enrolled1 locationNCT07495813
Recruiting
Not Applicable

Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial

Stable Coronary Artery Disease CAD
Beijing Anzhen Hospital1,312 enrolled5 locationsNCT07341932
Recruiting
Phase 3

Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)

Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Recruiting

Registry of Coronary Disease Outcomes Revascularizing With Drug-Coated Balloons

PaclitaxelACS (Acute Coronary Syndrome)CAD - Coronary Artery Disease+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3,000 enrolled1 locationNCT07231835
Recruiting

MCG is Clinically Applied to Evaluate Myocardial Ischemic Function in Patients With Stable Coronary Artery Disease

stable coronary artery disease
Nanhai Hospital, Guangdong Provincial People's Hospital291 enrolled1 locationNCT06123728
Recruiting

Assessment of Inflammatory mediator release, microvascular resistance, and plaque morphology after percutaneous coronary intervention in patients treated with colchicine.

stable coronary artery disease
The Heart Research Institute25 enrolled1 locationACTRN12619001449123
Recruiting

Assessment of relationship between segmental coronary endothelial function and plaque progression/regression

Stable coronary artery disease patients
Cardiovascular Investigation Unit, Royal Adelaide Hospital45 enrolled1 locationACTRN12612000594820